Osaic Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Osaic Holdings's BMY Position: Q2 2026 in Review
Osaic Holdings increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, buying an estimated $1.35M and bringing the position to 850,792 shares worth $49M. The position accounts for 0.06% of the portfolio, ranked #344.
Osaic Holdings first reported a position in BMY in Q1 2020 and has held it in 26 quarters since. The position peaked at $50.2M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Osaic Holdings held 850,792 shares of Bristol-Myers Squibb worth $49M as of Q2 2026.
- Osaic Holdings bought 23,539 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.35M.
- Bristol-Myers Squibb made up 0.06% of Osaic Holdings's portfolio in Q2 2026, its #344 holding.
- Osaic Holdings first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's Bristol-Myers Squibb position peaked at $50.2M in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.